secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001213900-24-086918
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bionomics director Aaron Weaver resigns from board effective Oct 9, 2024
------------------------------------------------------------------------

- Aaron Weaver resigned from Bionomics' Board of Directors on October 9, 2024.
- Resignation does not involve any disagreement on operations, policies, or practices.
- Weaver served on the board for four years; company thanked him and wished him well.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024086918/0001213900-24-086918-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024086918/ea021734401-8k_bionomics.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-086918

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer